#SatStats: What Percentage of the World’s Orthopedic Stem Cell Research Literature Has Regenexx Published?

By /

orthopedic stem cell research

Its #SatStats again, a time when we get our viewers involved in our research. This past week we had another peer reviewed publication accepted, this time on data from our registry on hip arthritis patients. With this publication, we add to the number of patients we’ve treated relative to the number that have been published world-wide who have received orthopedic stem cells treatments (bone marrow). For #SatStat, you can win $1,000 off a Regenexx-SD stem cell treatment if you guess the correct percentage of the world’s literature Regenexx has published when you add this new paper.

For some background, the research publications on the use of bone marrow stem cells for orthopedic injuries go back to 1997. I put together an infographic on approximately 99% of the orthopedic stem cell research papers and the number of patients treated for each. The contest will be based on this document, to make sure everyone’s on a level playing field. So if you add up all of the patient numbers (n’s) in the document for our research and then add up all from the entire document, you’ll get a rough percentage before the hip paper was accepted for publication. That percentage represents the fraction of patients Regenexx has published versus the total ever published. The hip paper also has a certain number of patients treated, so your guess for that number needs to be added to both patient n’s (our patients and the total) and then the percentage re-figured.

The $1,000 off only applies to Colorado and the guess has to be placed on our Twitter feed or Facebook post. I’ll announce the winner on Monday. Since this will involve a small change in percentage, your percentage guess needs to be three decimal places (i.e. 25.956%). The closest to the actual number gets the $1,000 off a Regenexx-SD procedure. Happy guessing!

Join us for a free Regenexx webinar.
Chris Centeno, MD is a specialist in regenerative medicine and the new field of Interventional Orthopedics. Centeno pioneered orthopedic stem cell procedures in 2005 and is responsible for a large amount of the published research on stem cell use for orthopedic applications. View Profile

If you have questions or comments about this blog post, please email us at [email protected]

NOTE: This blog post provides general information to help the reader better understand regenerative medicine, musculoskeletal health, and related subjects. All content provided in this blog, website, or any linked materials, including text, graphics, images, patient profiles, outcomes, and information, are not intended and should not be considered or used as a substitute for medical advice, diagnosis, or treatment. Please always consult with a professional and certified healthcare provider to discuss if a treatment is right for you.

Get Blog Updates by Email

By submitting the form, you are agreeing that you read and consent to our Privacy Policy. We may also contact you via email, phone, and other electronic means to communicate information about our products and services. We do not sell, or share your information to third party vendors.

Category: Contest, Latest News
Copyright © Regenexx 2021. All rights reserved.



9035 Wadsworth Pkwy #1000
Westminster, CO 80021


*DISCLAIMER: Like all medical procedures, Regenexx® Procedures have a success and failure rate. Patient reviews and testimonials on this site should not be interpreted as a statement on the effectiveness of our treatments for anyone else.

Providers listed on the Regenexx website are for informational purposes only and are not a recommendation from Regenexx for a specific provider or a guarantee of the outcome of any treatment you receive.